How ‘Twist’ fuels breast cancers
December 5th, 2009 - 1:06 pm ICT by ANI ( Leave a comment )Washington, Dec 5 (ANI): A research team led by Indian-origin researcher from John Hopkins University has identified a protein produced by a gene called ‘Twist’, that when present, drives aggressive, metastatic breast cancer from other breast cancer cells.
In the experiments, Hopkins team focused on the gene “Twist” (or TWIST1) - named for its winding shape - because of its known role as the producer of a so-called transcription factor, or protein that switches on or off other genes.
Twist is an oncogene, one of many genes we are born with that have the potential to turn normal cells into malignant ones.
“Our experiments show that Twist is a driving force among a lot of other players in causing some forms of breast cancer,” said Dr Venu Raman, associate professor of radiology and oncology, Johns Hopkins University School of Medicine.
“The protein it makes is one of a growing collection of markers that, when present, flag a tumour cell as a breast cancer stem cell,” Raman added.
Previous stem cell research identified a Twist-promoted process known as epithelial-to-mesenchymal transition, or EMT, as an important marker denoting the special subgroup of breast cancer stem cells
The study has shown that the presence of Twist, along with changes in two other biomarkers - CD 24 and CD44 - even without EMT, announces the presence of this critical sub-group of stem cells.
During the study, researchers worked with human breast cancer cells transplanted into mice, all of which had the oncogene Twist.
They tagged cell surface markers CD24 and CD44 with fluorescent chemicals. Following isolation of the subpopulation containing high CD44 and low CD24 by flow cytometry, they counted 20 of these putative breast cancer stem cells.
They then injected these cells into the breast tissue of 12 mice. All developed cancerous tumours.
Previously, the team showed that 65 percent of aggressive breast cancers have more Twist compared to lower-grade breast cancers, and that Twist-expressing cells are more resistant to radiation.
Raman suggests that Twist is integral to the breast cancer stem cell phenotype and has fundamental implications for early detection, treatment and prevention.
The study is published in journal Neoplasia (ANI)
- Silencing 'hedgehog' molecule halts cancer - Jun 06, 2011
- Cells responsible for bladder cancer's spread identified - Aug 07, 2009
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Prostate cancer cells more likely to spread with specific gene function loss - Feb 03, 2010
- Fish oil may hold key to leukaemia cure - Dec 23, 2011
- Key enzyme that controls growth of breast cancer cells identified - Nov 19, 2010
- Melanoma-initiating cell identified - Jul 01, 2010
- Biomakers that trigger aggressive liver cancer identified - Oct 21, 2009
- Blocking rogue gene could halt the spread of most cancers - Jan 25, 2011
- Wonder drug could kill all types of cancer - Jun 27, 2011
- Scientists crack genetic code for form of pancreatic cancer - Jan 21, 2011
- Gene causing lung cancer identified - Jan 07, 2012
- Genes linked to aggressive breast cancer identified - Aug 17, 2010
- Restoring gene may slow spread of advanced lung tumours - Nov 25, 2010
- Protein that protects against prostate cancer discovered - Feb 01, 2011
Tags: breast cancer, breast cancer cells, breast cancers, breast tissue, cancerous tumours, cd24, cell surface markers, flow cytometry, forms of breast cancer, hopkins team, human breast cancer, indian origin, john hopkins university, johns hopkins university, johns hopkins university school, johns hopkins university school of medicine, stem cell research, stem cells, transcription factor, tumour cell
